Description: Managed care networks are important to control rising health care costs . these need to be priced appropriately to produce the right results for all stakeholders . This includes analysis of utilization and costs for both in and out of network claims . A variety of risk and administrative service options exist for entities assuming such risk .

Description: Cell and Gene Therapy (CGT) are life-changing treatments where conditions such as cancer, hemophilia, spinal muscular atrophy and blindness are being cured. These are great for individuals and society, but the treatment costs are expensive which is bad for payers and reinsurers. This article explores ways for health reinsurance actuaries to participate in the space and evaluate the risk associated with these treatments

Description: Exploration of the relationship between insuretech and reinsurance in Life and P&C

Description: Re/insurance rates have been increasing since 2018, although pricing momentum has decelerated recently. Insurers and reinsurers are working to enhance profitability and improve the value proposition for clients in an environment of uncertainty about natural catastrophes, COVID-19-related losses, and social inflation, among other factors. This article describes drivers of the current underwriting cycle, compares it with past cycles, and provides considerations for the future.

Description: The observations and methodologies demonstrated in this article can help actuaries further analyze population mortality trends by causes of death and by socioeconomic status.

Description: Catastrophic exposure is on the rise owing to extreme weather and economic development of the past few years. Catastrophic claims peaked in 2017, but continue to pose a challenge to insurance markets. Global reinsurers seem to be well-capitalized despite the increase in CAT claims. But emerging insurance markets show a wide protection gap relative to more advance markets. Can reinsurance play a role in helping to narrow the gap? This article examines a few ideas.

Description: This article provides an update, as of September 2019, on the Reinsurance Section’s sponsored research in process and studies recently completed.

Description: Description of the world of reinsurance around the time the Reinsurance Section was formed.

Description: Summary and discussion of the results of the 2002 Munich American annual survey on life reinsurance.

Description: As the title of this corner suggests, our industry has many challenges and issues yet to address. This article focuses on the directions for the industry and the Reinsurance Section, on multiple levels. This includes the development of an up-to-date directory of reinsurers by various lines of business and the upcoming Re-Focus Summit 2006 featuring risk management and reinsurance.